Request for Covid-19 Impact Assessment of this Report
The United States Adoptive Cell Transfer Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Adoptive Cell Transfer Therapy market, reaching US$ million by the year 2028. As for the Europe Adoptive Cell Transfer Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Adoptive Cell Transfer Therapy players cover Novartis AG, Kite Pharma, Pfizer, and Juno Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Adoptive Cell Transfer Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
NK
LAK
DC
CIK
CTL
TIL
TCR-T
CAR-T
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Acute Lymphocytic Leukemia
NHL
Melanoma
Bladder Cancer
Lung Cancer
Head and Neck Cancer
Multiple Myeloma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Adaptimmune
Altor Bioscience Corporation
Cellectis
Takara Bio
Unum Therapeutics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adoptive Cell Transfer Therapy Market Size 2017-2028
2.1.2 Adoptive Cell Transfer Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Adoptive Cell Transfer Therapy Segment by Type
2.2.1 NK
2.2.2 LAK
2.2.3 DC
2.2.4 CIK
2.2.5 CTL
2.2.6 TIL
2.2.7 TCR-T
2.2.8 CAR-T
2.3 Adoptive Cell Transfer Therapy Market Size by Type
2.3.1 Adoptive Cell Transfer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
2.4 Adoptive Cell Transfer Therapy Segment by Application
2.4.1 Acute Lymphocytic Leukemia
2.4.2 NHL
2.4.3 Melanoma
2.4.4 Bladder Cancer
2.4.5 Lung Cancer
2.4.6 Head and Neck Cancer
2.4.7 Multiple Myeloma
2.4.8 Other
2.5 Adoptive Cell Transfer Therapy Market Size by Application
2.5.1 Adoptive Cell Transfer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
3 Adoptive Cell Transfer Therapy Market Size by Player
3.1 Adoptive Cell Transfer Therapy Market Size Market Share by Players
3.1.1 Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2022)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adoptive Cell Transfer Therapy by Regions
4.1 Adoptive Cell Transfer Therapy Market Size by Regions (2017-2022)
4.2 Americas Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
4.3 APAC Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
4.4 Europe Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
5.2 Americas Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
5.3 Americas Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adoptive Cell Transfer Therapy Market Size by Region (2017-2022)
6.2 APAC Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
6.3 APAC Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Adoptive Cell Transfer Therapy by Country (2017-2022)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adoptive Cell Transfer Therapy by Region (2017-2022)
8.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Adoptive Cell Transfer Therapy Market Forecast
10.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2023-2028)
10.1.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Adoptive Cell Transfer Therapy Forecast
10.1.3 APAC Adoptive Cell Transfer Therapy Forecast
10.1.4 Europe Adoptive Cell Transfer Therapy Forecast
10.1.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast
10.2 Americas Adoptive Cell Transfer Therapy Forecast by Country (2023-2028)
10.2.1 United States Adoptive Cell Transfer Therapy Market Forecast
10.2.2 Canada Adoptive Cell Transfer Therapy Market Forecast
10.2.3 Mexico Adoptive Cell Transfer Therapy Market Forecast
10.2.4 Brazil Adoptive Cell Transfer Therapy Market Forecast
10.3 APAC Adoptive Cell Transfer Therapy Forecast by Region (2023-2028)
10.3.1 China Adoptive Cell Transfer Therapy Market Forecast
10.3.2 Japan Adoptive Cell Transfer Therapy Market Forecast
10.3.3 Korea Adoptive Cell Transfer Therapy Market Forecast
10.3.4 Southeast Asia Adoptive Cell Transfer Therapy Market Forecast
10.3.5 India Adoptive Cell Transfer Therapy Market Forecast
10.3.6 Australia Adoptive Cell Transfer Therapy Market Forecast
10.4 Europe Adoptive Cell Transfer Therapy Forecast by Country (2023-2028)
10.4.1 Germany Adoptive Cell Transfer Therapy Market Forecast
10.4.2 France Adoptive Cell Transfer Therapy Market Forecast
10.4.3 UK Adoptive Cell Transfer Therapy Market Forecast
10.4.4 Italy Adoptive Cell Transfer Therapy Market Forecast
10.4.5 Russia Adoptive Cell Transfer Therapy Market Forecast
10.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Adoptive Cell Transfer Therapy Market Forecast
10.5.2 South Africa Adoptive Cell Transfer Therapy Market Forecast
10.5.3 Israel Adoptive Cell Transfer Therapy Market Forecast
10.5.4 Turkey Adoptive Cell Transfer Therapy Market Forecast
10.5.5 GCC Countries Adoptive Cell Transfer Therapy Market Forecast
10.6 Global Adoptive Cell Transfer Therapy Forecast by Type (2023-2028)
10.7 Global Adoptive Cell Transfer Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Offered
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Offered
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Adoptive Cell Transfer Therapy Product Offered
11.3.3 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Information
11.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Juno Therapeutics Main Business Overview
11.4.5 Juno Therapeutics Latest Developments
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Information
11.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Celgene Corporation Main Business Overview
11.5.5 Celgene Corporation Latest Developments
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Information
11.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 CARsgen Therapeutics Main Business Overview
11.6.5 CARsgen Therapeutics Latest Developments
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Information
11.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sorrento Therapeutics Main Business Overview
11.7.5 Sorrento Therapeutics Latest Developments
11.8 Legend Biotech
11.8.1 Legend Biotech Company Information
11.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Offered
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Legend Biotech Main Business Overview
11.8.5 Legend Biotech Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Information
11.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Aurora Biopharma Main Business Overview
11.10.5 Aurora Biopharma Latest Developments
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Information
11.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Autolus Therapeutics PLC Main Business Overview
11.11.5 Autolus Therapeutics PLC Latest Developments
11.12 Bluebird
11.12.1 Bluebird Company Information
11.12.2 Bluebird Adoptive Cell Transfer Therapy Product Offered
11.12.3 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bluebird Main Business Overview
11.12.5 Bluebird Latest Developments
11.13 Carina Biotech
11.13.1 Carina Biotech Company Information
11.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Offered
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Carina Biotech Main Business Overview
11.13.5 Carina Biotech Latest Developments
11.14 Athenex
11.14.1 Athenex Company Information
11.14.2 Athenex Adoptive Cell Transfer Therapy Product Offered
11.14.3 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Athenex Main Business Overview
11.14.5 Athenex Latest Developments
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Information
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Main Business Overview
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Information
11.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Hengrui Yuanzheng Main Business Overview
11.16.5 Hengrui Yuanzheng Latest Developments
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Information
11.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Eureka Therapeutics Main Business Overview
11.17.5 Eureka Therapeutics Latest Developments
11.18 WuXi Juno
11.18.1 WuXi Juno Company Information
11.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Offered
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 WuXi Juno Main Business Overview
11.18.5 WuXi Juno Latest Developments
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Information
11.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Shenzhen Inno Immunity Main Business Overview
11.19.5 Shenzhen Inno Immunity Latest Developments
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Information
11.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Shenzhen Binde Bio Main Business Overview
11.20.5 Shenzhen Binde Bio Latest Developments
11.21 Kerui Bio
11.21.1 Kerui Bio Company Information
11.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Offered
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Kerui Bio Main Business Overview
11.21.5 Kerui Bio Latest Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Information
11.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Offered
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Adaptimmune Main Business Overview
11.22.5 Adaptimmune Latest Developments
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Information
11.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Altor Bioscience Corporation Main Business Overview
11.23.5 Altor Bioscience Corporation Latest Developments
11.24 Cellectis
11.24.1 Cellectis Company Information
11.24.2 Cellectis Adoptive Cell Transfer Therapy Product Offered
11.24.3 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Cellectis Main Business Overview
11.24.5 Cellectis Latest Developments
11.25 Takara Bio
11.25.1 Takara Bio Company Information
11.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Offered
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Takara Bio Main Business Overview
11.25.5 Takara Bio Latest Developments
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Information
11.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Unum Therapeutics Main Business Overview
11.26.5 Unum Therapeutics Latest Developments
12 Research Findings and Conclusion
Table 1. Adoptive Cell Transfer Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of NK
Table 3. Major Players of LAK
Table 4. Major Players of DC
Table 5. Major Players of CIK
Table 6. Major Players of CTL
Table 7. Major Players of TIL
Table 8. Major Players of TCR-T
Table 9. Major Players of CAR-T
Table 10. Adoptive Cell Transfer Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 12. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
Table 13. Adoptive Cell Transfer Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 14. Global Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 15. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
Table 16. Global Adoptive Cell Transfer Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 17. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player (2020-2022)
Table 18. Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
Table 19. Adoptive Cell Transfer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Adoptive Cell Transfer Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions (2017-2022)
Table 24. Americas Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 25. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Country (2017-2022)
Table 26. Americas Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
Table 28. Americas Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
Table 30. APAC Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 31. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region (2017-2022)
Table 32. APAC Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
Table 34. APAC Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
Table 36. Europe Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 37. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country (2017-2022)
Table 38. Europe Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
Table 42. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region (2017-2022)
Table 44. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type (2017-2022)
Table 46. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application (2017-2022)
Table 48. Key Market Drivers & Growth Opportunities of Adoptive Cell Transfer Therapy
Table 49. Key Market Challenges & Risks of Adoptive Cell Transfer Therapy
Table 50. Key Industry Trends of Adoptive Cell Transfer Therapy
Table 51. Global Adoptive Cell Transfer Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 52. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 53. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 54. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 55. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 56. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 57. Novartis AG Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 58. Novartis AG Adoptive Cell Transfer Therapy Product Offered
Table 59. Novartis AG Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis AG Main Business
Table 61. Novartis AG Latest Developments
Table 62. Kite Pharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 63. Kite Pharma Adoptive Cell Transfer Therapy Product Offered
Table 64. Kite Pharma Main Business
Table 65. Kite Pharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Kite Pharma Latest Developments
Table 67. Pfizer Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 68. Pfizer Adoptive Cell Transfer Therapy Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Pfizer Latest Developments
Table 72. Juno Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 73. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 74. Juno Therapeutics Main Business
Table 75. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Juno Therapeutics Latest Developments
Table 77. Celgene Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 78. Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
Table 79. Celgene Corporation Main Business
Table 80. Celgene Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Celgene Corporation Latest Developments
Table 82. CARsgen Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 83. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 84. CARsgen Therapeutics Main Business
Table 85. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. CARsgen Therapeutics Latest Developments
Table 87. Sorrento Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 88. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 89. Sorrento Therapeutics Main Business
Table 90. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Sorrento Therapeutics Latest Developments
Table 92. Legend Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 93. Legend Biotech Adoptive Cell Transfer Therapy Product Offered
Table 94. Legend Biotech Main Business
Table 95. Legend Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Legend Biotech Latest Developments
Table 97. Atara Biotherapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 98. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
Table 99. Atara Biotherapeutics Main Business
Table 100. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Atara Biotherapeutics Latest Developments
Table 102. Aurora Biopharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 103. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
Table 104. Aurora Biopharma Main Business
Table 105. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Aurora Biopharma Latest Developments
Table 107. Autolus Therapeutics PLC Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 108. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
Table 109. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Autolus Therapeutics PLC Main Business
Table 111. Autolus Therapeutics PLC Latest Developments
Table 112. Bluebird Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 113. Bluebird Adoptive Cell Transfer Therapy Product Offered
Table 114. Bluebird Main Business
Table 115. Bluebird Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Bluebird Latest Developments
Table 117. Carina Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 118. Carina Biotech Adoptive Cell Transfer Therapy Product Offered
Table 119. Carina Biotech Main Business
Table 120. Carina Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Carina Biotech Latest Developments
Table 122. Athenex Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 123. Athenex Adoptive Cell Transfer Therapy Product Offered
Table 124. Athenex Main Business
Table 125. Athenex Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Athenex Latest Developments
Table 127. Xiangxue Pharmaceutical (Xiangxue Precision) Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 128. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
Table 129. Xiangxue Pharmaceutical (Xiangxue Precision) Main Business
Table 130. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
Table 132. Hengrui Yuanzheng Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 133. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
Table 134. Hengrui Yuanzheng Main Business
Table 135. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Hengrui Yuanzheng Latest Developments
Table 137. Eureka Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 138. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 139. Eureka Therapeutics Main Business
Table 140. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. Eureka Therapeutics Latest Developments
Table 142. WuXi Juno Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 143. WuXi Juno Adoptive Cell Transfer Therapy Product Offered
Table 144. WuXi Juno Main Business
Table 145. WuXi Juno Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 146. WuXi Juno Latest Developments
Table 147. Shenzhen Inno Immunity Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 148. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
Table 149. Shenzhen Inno Immunity Main Business
Table 150. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 151. Shenzhen Inno Immunity Latest Developments
Table 152. Shenzhen Binde Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 153. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
Table 154. Shenzhen Binde Bio Main Business
Table 155. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 156. Shenzhen Binde Bio Latest Developments
Table 157. Kerui Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 158. Kerui Bio Adoptive Cell Transfer Therapy Product Offered
Table 159. Kerui Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 160. Kerui Bio Main Business
Table 161. Kerui Bio Latest Developments
Table 162. Adaptimmune Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 163. Adaptimmune Adoptive Cell Transfer Therapy Product Offered
Table 164. Adaptimmune Main Business
Table 165. Adaptimmune Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 166. Adaptimmune Latest Developments
Table 167. Altor Bioscience Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 168. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
Table 169. Altor Bioscience Corporation Main Business
Table 170. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 171. Altor Bioscience Corporation Latest Developments
Table 172. Cellectis Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 173. Cellectis Adoptive Cell Transfer Therapy Product Offered
Table 174. Cellectis Main Business
Table 175. Cellectis Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 176. Cellectis Latest Developments
Table 177. Takara Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 178. Takara Bio Adoptive Cell Transfer Therapy Product Offered
Table 179. Takara Bio Main Business
Table 180. Takara Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 181. Takara Bio Latest Developments
Table 182. Unum Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 183. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 184. Unum Therapeutics Main Business
Table 185. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 186. Unum Therapeutics Latest Developments
List of Figures
Figure 1. Adoptive Cell Transfer Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adoptive Cell Transfer Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021
Figure 7. Adoptive Cell Transfer Therapy in Acute Lymphocytic Leukemia
Figure 8. Global Adoptive Cell Transfer Therapy Market: Acute Lymphocytic Leukemia (2017-2022) & ($ Millions)
Figure 9. Adoptive Cell Transfer Therapy in NHL
Figure 10. Global Adoptive Cell Transfer Therapy Market: NHL (2017-2022) & ($ Millions)
Figure 11. Adoptive Cell Transfer Therapy in Melanoma
Figure 12. Global Adoptive Cell Transfer Therapy Market: Melanoma (2017-2022) & ($ Millions)
Figure 13. Adoptive Cell Transfer Therapy in Bladder Cancer
Figure 14. Global Adoptive Cell Transfer Therapy Market: Bladder Cancer (2017-2022) & ($ Millions)
Figure 15. Adoptive Cell Transfer Therapy in Lung Cancer
Figure 16. Global Adoptive Cell Transfer Therapy Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 17. Adoptive Cell Transfer Therapy in Head and Neck Cancer
Figure 18. Global Adoptive Cell Transfer Therapy Market: Head and Neck Cancer (2017-2022) & ($ Millions)
Figure 19. Adoptive Cell Transfer Therapy in Multiple Myeloma
Figure 20. Global Adoptive Cell Transfer Therapy Market: Multiple Myeloma (2017-2022) & ($ Millions)
Figure 21. Adoptive Cell Transfer Therapy in Other
Figure 22. Global Adoptive Cell Transfer Therapy Market: Other (2017-2022) & ($ Millions)
Figure 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
Figure 24. Global Adoptive Cell Transfer Therapy Revenue Market Share by Player in 2021
Figure 25. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions (2017-2022)
Figure 26. Americas Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
Figure 27. APAC Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
Figure 28. Europe Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
Figure 29. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2017-2022 ($ Millions)
Figure 30. Americas Adoptive Cell Transfer Therapy Value Market Share by Country in 2021
Figure 31. Americas Adoptive Cell Transfer Therapy Consumption Market Share by Type in 2021
Figure 32. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
Figure 33. United States Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Canada Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Mexico Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 36. Brazil Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 37. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2021
Figure 38. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
Figure 39. China Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. Japan Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Korea Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Southeast Asia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. India Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 44. Australia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 45. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country in 2021
Figure 46. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021
Figure 47. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
Figure 48. Germany Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. France Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. UK Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Italy Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 52. Russia Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 53. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region in 2021
Figure 54. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type in 2021
Figure 55. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application in 2021
Figure 56. Egypt Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 57. South Africa Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 58. Israel Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 59. Turkey Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Adoptive Cell Transfer Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 61. Americas Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 62. APAC Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 63. Europe Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Middle East & Africa Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 65. United States Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 66. Canada Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 67. Mexico Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Brazil Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 69. China Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Japan Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Korea Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 72. Southeast Asia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 73. India Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Australia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 75. Germany Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 76. France Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 77. UK Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 78. Italy Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 79. Russia Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 80. Spain Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 81. Egypt Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 82. South Africa Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 83. Israel Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 84. Turkey Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
Figure 85. GCC Countries Adoptive Cell Transfer Therapy Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...